Barclays
CELG

Barclays’s Celgene Corp CELG Stock Holding History

Barclays’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,134,829
Closed -$411M – 7237
2019
Q3 		$411M Buy
4,134,829
+310,027
+8% +$29.5M 0.26% 63
2019
Q2 		$354M Buy
3,824,802
+883,155
+30% +$83.9M 0.22% 74
2019
Q1 		$278M Buy
2,941,647
+997,326
+51% +$87.2M 0.19% 76
2018
Q4 		$125M Buy
1,944,321
+116,212
+6% +$8.58M 0.1% 148
2018
Q3 		$164M Buy
1,828,109
+189,168
+12% +$16.7M 0.11% 133
2018
Q2 		$130M Sell
1,638,941
-56,913
-3% -$4.73M 0.11% 147
2018
Q1 		$151M Buy
1,695,854
+404,616
+31% +$38.8M 0.12% 147
2017
Q4 		$135M Buy
1,291,238
+733,133
+131% +$82.7M 0.11% 147
2017
Q3 		$81.4M Sell
558,105
-299,588
-35% -$40.8M 0.08% 193
2017
Q2 		$111M Buy
857,693
+248,922
+41% +$30.5M 0.12% 121
2017
Q1 		$75.7M Buy
608,771
+300,148
+97% +$35.9M 0.08% 180
2016
Q4 		$35.7M Sell
308,623
-127,424
-29% -$14.2M 0.04% 366
2016
Q3 		$45.6M Sell
436,047
-24,316
-5% -$2.63M 0.05% 273
2016
Q2 		$45.4M Sell
460,363
-69,476
-13% -$7.19M 0.06% 275
2016
Q1 		$53M Sell
529,839
-209,118
-28% -$21.5M 0.08% 199
2015
Q4 		$87.9M Buy
738,957
+96,936
+15% +$11.2M 0.11% 168
2015
Q3 		$69.3M Sell
642,021
-47,291
-7% -$5.87M 0.08% 205
2015
Q2 		$79.3M Sell
689,312
-22,067
-3% -$2.52M 0.09% 188
2015
Q1 		$81.8M Sell
711,379
-695,804
-49% -$83.1M 0.09% 195
2014
Q4 		$156M Buy
1,407,183
+298,349
+27% +$31.5M 0.15% 99
2014
Q3 		$104M Sell
1,108,834
-123,505
-10% -$11.1M 0.1% 154
2014
Q2 		$105M Sell
1,232,339
-519,049
-30% -$39.5M 0.11% 135
2014
Q1 		$122M Sell
1,751,388
-85,904
-5% -$6.8M 0.14% 123
2013
Q4 		$154M Buy
1,837,292
+573,626
+45% +$45.4M 0.16% 87
2013
Q3 		$97.3M Buy
1,263,666
+462,904
+58% +$32.4M 0.12% 121
2013
Q2 		$46.8M Buy
+800,762
New +$48.2M 0.06% 276

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Barclays's CELG Position: Q4 2019 in Review

Barclays sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,134,829 shares — an estimated $411M sold.

Barclays first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $411M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Barclays reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Barclays sold 4,134,829 Celgene Corp shares in Q4 2019, an estimated $411M.
  • Barclays first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Barclays's Celgene Corp position peaked at $411M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.